Page last updated: 2024-09-05

zm 241385 and 4-(1h-imidazol-4-ylmethyl)piperidine

zm 241385 has been researched along with 4-(1h-imidazol-4-ylmethyl)piperidine in 1 studies

Compound Research Comparison

Studies
(zm 241385)
Trials
(zm 241385)
Recent Studies (post-2010)
(zm 241385)
Studies
(4-(1h-imidazol-4-ylmethyl)piperidine)
Trials
(4-(1h-imidazol-4-ylmethyl)piperidine)
Recent Studies (post-2010) (4-(1h-imidazol-4-ylmethyl)piperidine)
401312470021

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arias-Montaño, JA; Escamilla-Sánchez, J; González-Pantoja, R; Márquez-Gómez, R; Morales-Figueroa, GE1

Other Studies

1 other study(ies) available for zm 241385 and 4-(1h-imidazol-4-ylmethyl)piperidine

ArticleYear
Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes.
    ACS chemical neuroscience, 2014, Aug-20, Volume: 5, Issue:8

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Biphenyl Compounds; gamma-Aminobutyric Acid; Globus Pallidus; Histamine Agonists; Histamine H3 Antagonists; Imidazoles; Male; Membrane Potentials; Nitriles; Phenethylamines; Piperidines; Potassium; Pyrrolidines; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Histamine H3; Synaptosomes; Thiourea; Triazines; Triazoles; Tritium

2014